Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.

A major limitation, Daskalakis said, is that the surveys were conducted an average of 49 days after the first exposure ...

At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...

Two examples of the Company’s speed advantage resulting from its internal innovation at scale: CDK4i entered the clinic in ...

Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...

In normal human physiology, relaxin is upregulated during pregnancy ... Tectonic is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that ...

Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $127.53, ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem ...

Strengthened Governance. ADMA has successfully engaged and onboarded KPMG as its new independent registered public accounting firm. This auditor transition to a “Big 4” firm is a testament to the ...